☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
SeaStar Medical
SeaStar Medical Receives Canadian Patent Claiming Coverage of its Selective Cytopheretic Device Technology
February 2, 2024
SeaStar Medical Signed US License and Distribution Agreement with Nuwellis for Selective Cytopheretic Device to Treat Acute Kidney...
December 30, 2022
SeaStar Medical and LMF Published Results of Selective Cytopheretic Device in (Pilot SCD 005) Study for COVID-19 in SCCM 2022, Cri...
June 8, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.
